ANTIBIOTIC RESISTANCE OF MICROORGANISMS ISOLATED FROM MILK

被引:13
作者
Hadzevych, O. V. [1 ,2 ]
Paliy, A. P. [1 ,2 ,4 ]
Kinash, O. V. [1 ,2 ]
Petrov, R. V. [1 ,3 ]
Paliy, A. P. [1 ,2 ,4 ]
Herylovych, A. V. [1 ,4 ]
机构
[1] Inst Expt & Clin Vet Med, Natl Sci Ctr, Kharkov, Ukraine
[2] Ukrainian Med Dent Acad, Poltava, Ukraine
[3] Sumy Natl Agrarian Univ, Sumy Oblast, Ukraine
[4] Kharkiv Natl Tech Univ Agr Petra Vasylenka, Kharkov, Ukraine
来源
WORLD OF MEDICINE AND BIOLOGY | 2019年 / 69卷 / 03期
关键词
antibiotic resistance; antibiotic; cow mastitis; milk; Staphylococcus; Streptococcus; E; coli; STAPHYLOCOCCUS-AUREUS;
D O I
10.26724/2079-8334-2019-3-69-245-250
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The performed literature analysis has shown that the resistance of microorganisms to antibacterial drugs remains a global problem all over the world. It has been established that in the etiological structure of mastitis of cows in cattle farms of Ukraine prevail Staphylococcus spp. (45.0 %), Streptococcus spp. (29.3 %) and Escherichia coli (17.8 %). The causative agents of staphylococcal etiology have pathogenicity factors, namely, plasmocoagulase (55.8 %), lecithinase (75.6 %) and hemolysins (79.1 %); resistance to Benzylpenicillinum (55.8 %), Oxacillin (30.3 %), Tetracyclin (89.6 %), Azithromycin (63.9 %), Erythromycin (55.8 %). E..oli and Streptococcus spp. has the highest (p=0.0001; p=0.0008) resistance to Tetracyclin (73.5 %, 58.9 %), Cefazolin (64.7 %, 37.5 %) and Doxycycline (58.8 %, 53.6 %), the smallest (p=0.0001; p=0.0008) to fluoroquinolones.
引用
收藏
页码:245 / 250
页数:6
相关论文
共 11 条
[1]  
Bergilevich AN, 2017, ANALIZ ANTIBIOTIKORE, V20, P303
[2]  
Berhilevych OM, 2017, REGUL MECH BIOSYST, V8, P559, DOI 10.15421/021786
[3]   The European Union summary report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2016 [J].
European Food Safety Authority, European Centre for Disease Prevention and Control .
EFSA JOURNAL, 2018, 16 (02)
[5]  
Harkavenko TO, 2017, VET BIOTEKHNOLOHIYA, V31, P33
[6]  
JAMIL S, 2017, J PHARM RES, V1, P21
[7]  
Kasyanchuk VV, 2018, VET BIOTEKHNOLOHIYA, V32, P107
[8]  
Kasyanchuk VV, 2016, ZBIRNYK NAUKOVYKH PR, V32, P249
[9]  
Khoult Dzh, 1994, OPREDELITEL BAKTERIY, V2
[10]  
MOREILLON P, 1994, J CHEMOTHERAPY, V6, P51